We are live on
!
Find out more
ROTUOC
Regents of the University of California Portfolio holdings
AUM
$4.36B
1-Year Est. Return
33.89%
This Fund
S&P 500
This Quarter
Est. Return
+17.63%
1 Year Est. Return
+33.89%
3 Year Est. Return
+86.09%
5 Year Est. Return
+63.96%
10 Year Est. Return
+870.04%
AUM
$713M
AUM Growth
+$41.4M
(+6.2%)
Cap. Flow
-$22.7M
Cap. Flow
% of AUM
-3.18%
Top 10 Holdings %
Top 10 Hldgs %
97.49%
Holding
35
New
5
Increased
3
Reduced
3
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Blue Owl Capital
OBDC
|
+$529M |
| 2 |
RAPT
RAPT Therapeutics
RAPT
|
+$30.4M |
| 3 |
ORTX
Orchard Therapeutics plc American Depositary Shares
ORTX
|
+$7.8M |
| 4 |
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
|
+$1.7M |
| 5 |
The RealReal
REAL
|
+$471K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Allogene Therapeutics
ALLO
|
+$38.8M |
| 2 |
CNST
Constellation Pharmaceuticals, Inc.
CNST
|
+$9.37M |
| 3 |
Guardant Health
GH
|
+$2.17M |
| 4 |
XYZ
Block Inc
XYZ
|
+$936K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 74.73% |
| 2 | Healthcare | 22.43% |
| 3 | Consumer Staples | 1% |
| 4 | Materials | 0.35% |
| 5 | Consumer Discretionary | 0.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Blue Owl Capital
OBDC
$5.75B
| $528M | 74.04% |
+42,783,344
| New | +$529M |
|
|
2
Allogene Therapeutics
ALLO
$714M
| $54.8M | 7.69% |
1,279,281
-1,071,649
| -46% | -$38.8M |
|
|
RAPT
3
DELISTED
RAPT Therapeutics
RAPT
| $45.6M | 6.4% |
+196,530
| New | +$30.4M |
|
|
CNST
4
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $37.2M | 5.22% |
1,237,406
-260,000
| -17% | -$9.37M |
|
|
5
Guardant Health
GH
$22.2B
| $11M | 1.54% |
135,273
-26,889
| -17% | -$2.17M |
|
6
Estee Lauder
EL
$31.7B
| $6.3M | 0.88% |
33,400
| – | – |
|
|
ORTX
7
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| $5.11M | 0.72% |
+85,120
| New | +$7.8M |
|
8
Air Products & Chemicals
APD
$67.7B
| $2.46M | 0.35% |
10,200
| – | – |
|
|
9
The RealReal
REAL
$1.36B
| $2.35M | 0.33% |
184,097
+39,583
| +27% | +$471K |
|
10
Intellia Therapeutics
NTLA
$1.69B
| $2.34M | 0.33% |
111,440
| – | – |
|
11
S&P Global
SPGI
$121B
| $1.98M | 0.28% |
6,000
| – | – |
|
|
12
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.2B
| $1.82M | 0.26% |
+5,600
| New | +$1.7M |
|
13
Merck
MRK
$328B
| $1.67M | 0.23% |
22,637
| – | – |
|
14
ExxonMobil
XOM
$657B
| $1.5M | 0.21% |
33,600
| – | – |
|
15
Berkshire Hathaway Class B
BRK.B
$1.09T
| $1.44M | 0.2% |
8,043
| – | – |
|
16
Verizon
VZ
$195B
| $978K | 0.14% |
17,735
| – | – |
|
17
Pfizer
PFE
$150B
| $904K | 0.13% |
29,138
| – | – |
|
|
GBT
18
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $879K | 0.12% |
13,928
| – | – |
|
19
Texas Instruments
TXN
$253B
| $825K | 0.12% |
6,500
| – | – |
|
20
Coca-Cola
KO
$373B
| $804K | 0.11% |
18,000
| – | – |
|
21
Walt Disney
DIS
$178B
| $669K | 0.09% |
6,000
| – | – |
|
22
AT&T
T
$166B
| $656K | 0.09% |
28,715
| – | – |
|
23
Honeywell
HON
$74.6B
| $611K | 0.09% |
4,481
| – | – |
|
|
MRSH
24
Marsh
MRSH
$90.1B
| $558K | 0.08% |
5,200
| – | – |
|
25
Zoom
ZM
$30.8B
| $545K | 0.08% |
2,149
+430
| +25% | +$77.4K |
|
Similar funds
SFM
EC
EQF
NEI
FIS
CAU
IUHSA
CW
Regents of the University of California's Q2 2020 Portfolio in Review
As of Q2 2020, Regents of the University of California held 35 positions worth $713M, up 6.2% from $671M the previous quarter. Its ten largest holdings account for 97% of the portfolio.
Regents of the University of California withdrew a net $22.7M in Q2 2020, closing 4 positions and reducing 3 holdings. Its most notable exit was Block Inc, an estimated $936K position sold in full.
By sector, the portfolio is most concentrated in Financials at 75% of assets, up from 0.6% a quarter earlier, followed by Healthcare and Consumer Staples.
Against the trend, Regents of the University of California opened a new position in Blue Owl Capital worth $528M.
- Regents of the University of California's largest Q2 2020 buy was Blue Owl Capital: 42,783,344 shares worth $528M.
- Regents of the University of California added most to The RealReal in Q2 2020, an estimated $471K increase.
- Regents of the University of California's biggest Q2 2020 reduction was Allogene Therapeutics, cutting an estimated $38.8M.
- Regents of the University of California fully exited Block Inc in Q2 2020, selling an estimated $936K.
- Regents of the University of California's ten largest holdings make up 97% of its $713M portfolio in Q2 2020.
- Regents of the University of California opened 5 new positions and closed 4 in Q2 2020.
- Regents of the University of California's portfolio value rose 6.2% quarter-over-quarter to $713M.
Based on Regents of the University of California's 13F filing for Q2 2020, filed 23 Jul 2020.